Johnson & Johnson attempting to patent anti-inflammatory drug
We are beginning to elucidate the relationship chronic inflammation has on mood disorders and neuronal disease, as for heart disease and other major diseases of the Western World. Eating a whole food plant based diet is the key. Simple right?
Wrong. Getting people to base their diet on health and survival rather than flavor is no easy task.
One cannot patent food. Enter big Pharma. Drug trials are being run by Johnson & Johnson, enrolling patients with depression at sites in Russia, Poland, Canada, and the United States. The company is testing an experimental drug called sirukumab, which blocks a key inflammatory protein called interleukin 6.
This is just the beginning of anti-inflammatory pills.